Incidence and Risk Factors for Gadolinium-Based Contrast Agent Immediate Reactions.
2016
AbstractSince their clinical introduction in 1988, gadolinium-based contrast agents (GBCAs) have demonstrated an excellent safety profile with a reported acute adverse reaction rate ranging from 0.01% to 2%. By comparison, the acute adverse reaction rate of low osmolar nonionic computed tomography c
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
73
References
38
Citations
NaN
KQI